These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37278240)

  • 21. Non-alcoholic fatty liver disease.
    Powell EE; Wong VW; Rinella M
    Lancet; 2021 Jun; 397(10290):2212-2224. PubMed ID: 33894145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease: Definition and subtypes.
    Han SK; Baik SK; Kim MY
    Clin Mol Hepatol; 2023 Feb; 29(suppl):S5-S16. PubMed ID: 36577427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth.
    Monga Kravetz A; Testerman T; Galuppo B; Graf J; Pierpont B; Siebel S; Feinn R; Santoro N
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3575-85. PubMed ID: 32561908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Muzurović E; Mikhailidis DP; Mantzoros C
    Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
    Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
    J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The change in prevalence of suspected non-alcoholic fatty liver disease in Korean adolescents from 2001 to 2017.
    Park SH; Park YE; Lee J; Choi JH; Heo NY; Park J; Kim TO; Hwang JS; Kim E; Oh EH; Jang HJ; Park HY; Kim HK
    Paediatr Int Child Health; 2020 Aug; 40(3):166-170. PubMed ID: 32223545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward.
    Boutari C; Polyzos SA; Mantzoros CS
    Metabolism; 2021 Sep; 122():154781. PubMed ID: 33901501
    [No Abstract]   [Full Text] [Related]  

  • 29. Association between non-alcoholic fatty liver disease and obstructive sleep apnea.
    Umbro I; Fabiani V; Fabiani M; Angelico F; Del Ben M
    World J Gastroenterol; 2020 May; 26(20):2669-2681. PubMed ID: 32523319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of health status, diet and lifestyle on non-alcoholic fatty liver disease: Narrative review.
    Alalwani J; Eljazzar S; Basil M; Tayyem R
    Clin Obes; 2022 Aug; 12(4):e12525. PubMed ID: 35412016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions.
    Li H; Hu B; Wei L; Zhou L; Zhang L; Lin Y; Qin B; Dai Y; Lu Z
    Eur J Neurol; 2018 Mar; 25(3):577-e34. PubMed ID: 29281159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults.
    Wei Y; Liu J; Wang G; Wang Y
    Biol Sex Differ; 2023 Oct; 14(1):69. PubMed ID: 37814297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-alcoholic fatty liver disease and type 2 diabetes: An update.
    Lee CH; Lui DT; Lam KS
    J Diabetes Investig; 2022 Jun; 13(6):930-940. PubMed ID: 35080136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-alcoholic fatty liver disease and childhood obesity.
    Shaunak M; Byrne CD; Davis N; Afolabi P; Faust SN; Davies JH
    Arch Dis Child; 2021 Jan; 106(1):3-8. PubMed ID: 32409495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
    Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
    J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis.
    Abdallah LR; de Matos RC; E Souza YPDM; Vieira-Soares D; Muller-Machado G; Pollo-Flores P
    Curr Atheroscler Rep; 2020 Feb; 22(1):7. PubMed ID: 32020371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease: A growing public health problem in Turkey.
    Kaya E; Yılmaz Y
    Turk J Gastroenterol; 2019 Oct; 30(10):865-871. PubMed ID: 31258135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in drug transport and metabolism and their clinical implications in non-alcoholic fatty liver disease.
    Dietrich CG; Rau M; Jahn D; Geier A
    Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):625-640. PubMed ID: 28359183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease.
    Li W; Alazawi W
    Clin Med (Lond); 2020 Sep; 20(5):509-512. PubMed ID: 32934047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.